1
Q
nitric oxide therapy
A
- must be >34 weeks gestation
- initial dose= 20ppm
- must be weaned to prevent rebound
- causes methemoglinemia
*pulm vasodilator
2
Q
PPHN treatment
A
- hyperventilation
- alkaine pH
- sodium bicarb to produce alkalemia
- inhaled nitric oxide
- tolazoline
- nitroprusside sodium
- dopamine`
3
Q
IRDS treatment
A
- O2 therapy
- if pH <7.25
- surfactant replacement
- thermoregulation
4
Q
transcutaneous PaCO2/O2 monitoring
A
- warms site to 43-45C
- site should be changed every 2-6hrs
- frequent calibration
5
Q
umbilical artery catheter complications
A
- infection
- thromboembolism
- air embolism
- hemorrhage
* use for no longer than 7 days
6
Q
nasal cannulas
A
- for long term therapy
2. work in increments of 0.25/0.50
7
Q
air-blender systems
A
incorporate
- alarm module
- pressure-balancing module
- proportioning module
8
Q
oxygen mist tent
A
tx of croup
21%-50% range
10-15L/min
9
Q
O2 hood
A
- provides 21%-100% O2
2. flows of at least 5L.min to prevent CO2 buildup
10
Q
APGAR evaluation
A
Appearance (color) Pulse (HR) Grimace (reflex irritability) Activity (muscle tone) Respiration (RR)
11
Q
maternal factors involved w high risk infants
A
- age
- diabetes
- drug/alcohol/tabacoo
- infections
- previousu c section
- prior birth w respiratory prblems
- lack of prenatal care
12
Q
causes of high risk infants
A
- PROM
- premature delivery
- postmature delivery
- meconium in amniotic fluid
- prolapsed cord
- prolonged labor
- abnormal fetal presentation
13
Q
central cyanosis
A
- mucus membranes/tongue/lips
2. must administer O2 immediately
14
Q
normal pulse (HR)
A
110-160 beats per min
15
Q
normal RR
A
30-60 breaths per min
16
Q
normal BP
A
60/40
17
Q
apneic periods
A
apnea of 10secs or more is abnormal
18
Q
transcutaneous error
A
airleaks will show higher PO2, lower PCO2
19
Q
capillary O2
A
PO2 values are normally lower than arterial PO2
normal PCO2 is 40-50
